Induction of CYP3A isoforms in cultured precisioncut human liver slices

References

• AZRI, S., GANDOLH, A. J. and BRENDEL, K., 1990, Precision-cut liver slices: an in vitro system for profiling potential hepatotoxicants. In Vitro Toxicology, 3, 309–320.
   Google Scholar
• BACH, P. H., VICKERS, A. E. M., FISHER, R., BAUMANN, A., BRITTEBO, E., CARLILE, D. J., KOSTER, H. J., LAKE, B. G., SALMON, F., SAWYER, T. W. and SKIBINSKI, G., 1996, The use of tissue slices for pharmacotoxicobgy studies. ATLA, 24, 893–923.
   Google Scholar
• BEAMAND J. A., PRICE, R. J., CUNNINGHAME, M. E. and LAKE, B. G.,1993, Culture of precision-cut liver slices: effect of some peroxisome proliferators. Food and Chemical Toxicology, 31, 137–147.
   PubMed Web of Science ®Google Scholar
• CONNEY, A. H., 1986, Induction of microsomalcytochrome P-450 enzymes: the first Bernard B. Brodie lecture at Pennsylvania State University. Life Sciences, 39, 2493–2518.
   Google Scholar
• CURI -PEDROSA, R., DAUJAT, M., PICHARD, L., OURLIN, J. C., CLAIR, P., GERVOT, L., LESCA, P., DOMERGUE, J., JoYEux, H., FOURTANIER, G. and MAUREL, P., 1994, Omeprazoleand lansoprazole are mixed inducers of CYP /A and CYP3 A in human hepatocytes in primary culture. Journal of Pharmacology and Experimental Therapeutics, 269, 384–392.
   Google Scholar
• DAUJAT, M., PICHARD, L., FABRE, I., PINEAU, T., FABRE, G., BONFILS, C. and MAUREL, P., 1991, Induction protocols for P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods in Enzymology, 206, 345–353.
   PubMed Web of Science ®Google Scholar
• DRAHUSHUK, A. T., MCGARRIGLE, B. P., TAI, H.-L., KITAREEWAN, S., GOLDSTEIN, J. A. and OLSON, J. A., 1996, Validationof precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicology and Applied Pharmacology, 140, 393–403.
   Google Scholar
• EDWARDS, R. J., MURRAY, B. P., MURRAY S., SCHULZ, T., NEUBERT, D., GANT, T. W., THORGEIRSSON S. S., BOOBIS, A. R. and DAVIES, D. S., 1994, Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and humans. Carcinogenesis, 15, 829–836.
   Google Scholar
• EDWARDS, R. J., MURRAY, B. P., SINGLETON, A. M., MURRAY, S., DAVIES, D. S. and BOOBIS, A. R.,1993, Identificationof the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man. Biochemical Pharmacology, 46, 213–220.
   PubMed Web of Science ®Google Scholar
• GOKHALE, M. S., BuNroN, T. E., ZURLO, J. and YAGER, J. D., 1995, Cytochrome P-450 1A1/1A2 induction,albuminsecretion, and histologicalchanges in cultured liver slices.InVitro Toxicology,, 8, 357–368.
   Google Scholar
• GONZALEZ, F. J., 1989, The molecular biology of cytochrome P450s. Pharmacological Reviews, 40, 243–288.
   Web of Science ®Google Scholar
• GREUET, J., PICHARD, L., BONFILS, C., DOMERGUE, J. and MAUREL, P., 1996, The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochemical and Biophysical Research Communications, 225, 689–694.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., 1987, Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism.In Biochemical Toxicology : A Practical Approach, edited by K. Snell and B. Mullock (Oxford: IRL Press), pp. 183–215.
   Google Scholar
• LAKE, B. G., 1997, In vitro methods. In Comprehensive Toxicology, vol. 9. Hepatic and Gastrointestina 1 Toxicology, edited by R. McCuskey and D. L. Earnest (New York: Elsevier), pp. 233–249.
   Google Scholar
• LAKE, B. G., BEAMAND J. A., JAPENGA, A. C., RENWICK, A., DAVIES, S. and PRICE, R. J., 1993, Induction of cytochrome P-450-dependent enzyme activities in cultured rat liver slices. Food and Chemical Toxicology, 31, 377–386.
   Google Scholar
• LAKE, B. G., CHARZAT, C TREDGER, J. M., RENWICK, A. B., BEAMAND J. A. and PRICE, R. J., 1996, Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices. Xenobiotka, 26, 297–306.
   Google Scholar
• LECLUYSE, E. L., BULLOCK, P. L. and PARKINSON, A., 1996, Strategies for restoration and maintenance of norm al hepatic structure and function in long-term cultures of rat hepatocytes. Advanced Drug Delivery Reviews, 22, 133–186.
   Web of Science ®Google Scholar
• LEWIS, D. F. V., EDDERSHAW, P. J., GoLDEAPP, P. S. and TARBIT, M. H., 1996, Molecular modellingof CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotka, 26, 1067–1086.
   Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MAUREL, P., 1996a, The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Advanced Drug Delivery Reviews, 22, 105–132.
   Web of Science ®Google Scholar
• MAUREL, P., 1996b, The CYP3 family. In Cytochrontes P450: Metabolic and Toxicological Aspects, edited by C. Ioannides (Boca Raton: CRC Press), pp. 241–270.
   Google Scholar
• MULLER D GLOCKNER, R. and ROST, M.,1996,Monooxygenation, cytochromeP4501A1 and P4501A1-mRNAin rat liverslices exposed to beta-naphthoflavoneand dexamethasonein vitro. Experimental Toxicology and Pathology, 48, 433–438.
   Google Scholar
• NELSON D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS I. C. and NEBERT D. W., 1996, P450 superfamily: update on new sequences, gene mapping,accession numbers and nomenclature. Pharmacogenetk s, 6, 1–42.
   Google Scholar
• OKEY, A. B., 1990, Enzyme induction in the cytochrome P-450 system. Pharmacology and Therapeutics, 45, 241–298.
   PubMed Web of Science ®Google Scholar
• PAINE, A. J., 1990, The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system. Chemko -Biological Interactions, 74, 1–31.
   PubMed Web of Science ®Google Scholar
• PAINE, A. J., 1996, Validity and reliability of in vitro systems in safety evaluation. Environmental Toxicology and Pharmacology, 2, 207–212.
   PubMedGoogle Scholar
• PARRISH, A. R., GANDOLFI, A. J. and BRENDEL, K., 1995, Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sciences, 57, 1887–1901.
   Web of Science ®Google Scholar
• PARKINSON, A., 1996, Biotransform ation of xenobiotics. In Casarett and Doull's Toxicology: The Bask Science of Poisons, 5th edn, edited by C. D. Klaassen (New York: McGraw-Hill), pp. 113–186.
   Google Scholar
• PICHARD, L., FABRE, I., DAUJAT, M., DOMERGUE, J., JOYEUX, H. and MAUREL, P., 1992, Effect Of corticosteroids on the expression of cytochromes P450 and cyclosporin A oxidase activity in primary cultures of human hepatocytes. Molecular Pharmacology, 41, 1047–1055.
   PubMed Web of Science ®Google Scholar
• PICHARD, L., FABRE, I., FABRE, G DOMERGUE, J., SAINT AUBERT, B., MOURAD, G. and MAUREL, P., 1990, Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and liver microsomes. Drug Metabolism and Disposition, 18, 595–606.
   Google Scholar
• SCHUETZ, J. D., BEACH, D. L. and GUZELIAN, P. S., 1994, Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetk s,4, 11–20.
   PubMedGoogle Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomesof 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SONDERFAN, A. J., ARLOTTO, M. P., DUTTON, D. R., MCKILLEN, S. K. and PARKINSON, A., 1987, Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Archives of Biochemistry and Biophysics, 255, 27–41.
   PubMed Web of Science ®Google Scholar
• WRIGHTON, S. A., BRIAN, W. R., SARI, M.-A., IWASAKI, M., GUENGERICH, F. P., RAUCY, J. L.,MOLOWA D. T. and VANDENBRANDEN, M., 1990, Studies on the expression and metabolic capabilities of human liver cytochromeP450IIIA5 (H Lp3). Molecular Pharmacology, 38, 207–213.
   Google Scholar
• WRIGHTON, S. A., VANDENBRANDEN, M., STEVENS, J. C., SHIPLEY, L. A., RING, B. J., RETTlE, A. E. and CASHMAN, J. R., 1993, In vitro methods for assessing human hepatic drug metabolism: their use in drug development.Drug Metabolism Reviews, 25, 453–484.
   PubMed Web of Science ®Google Scholar